Summary & Overview
CPT 82550: Creatine Kinase (CK) Total Laboratory Test
CPT code 82550 represents the laboratory analysis of total creatine kinase (CK) levels in blood, a key diagnostic tool for identifying muscle injury and cardiac events. This procedure is widely used in clinical settings to evaluate conditions such as myocardial infarction, rhabdomyolysis, and other disorders associated with abnormal enzyme levels. The test is performed as a chemistry procedure, most often in a laboratory environment.
Major national payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare. The publication provides an overview of payer coverage, typical billing practices, and relevant clinical contexts for the use of CPT code 82550. Readers will gain insights into common modifiers, associated provider taxonomies, and ICD-10 diagnoses linked to this code, as well as related CPT codes such as 82552 for CK isoenzymes.
This summary offers a comprehensive look at the clinical and billing landscape for creatine kinase testing, highlighting its importance in both routine and acute care. Policy updates, benchmarks, and payer-specific considerations are discussed to inform stakeholders about current trends and requirements for laboratory chemistry procedures.
CPT Code Overview
CPT code 82550 is used to report the laboratory measurement of creatine kinase (CK), also known as creatine phosphokinase (CPK), in a patient's blood. This test is classified under chemistry procedures and is typically performed in a laboratory setting, designated as Place of Service 81. The CK test is commonly utilized to assess muscle damage, including cardiac and skeletal muscle injury, and plays a critical role in diagnosing conditions such as myocardial infarction and rhabdomyolysis. The procedure involves quantifying the total CK enzyme activity, providing valuable information for clinical decision-making.
Clinical & Coding Specifications
Clinical Context
A patient presents to a clinic or hospital with symptoms such as muscle pain, weakness, or chest discomfort. The provider suspects possible muscle injury, myocardial infarction, or other conditions affecting muscle or heart tissue. A blood sample is collected and sent to a laboratory (Place of Service 81) for analysis. The laboratory performs the chemistry procedure for creatine kinase (CK) total, using CPT code 82550, to assess muscle enzyme levels. The results help the provider evaluate for conditions such as rhabdomyolysis, acute myocardial infarction, or abnormal serum enzyme levels, guiding further diagnostic or treatment decisions.
Coding Specifications
-
Modifier
26: Used when reporting only the professional component of the laboratory service, such as interpretation of results by a physician. -
Modifier
90: Used when the laboratory test is performed by a reference (outside) laboratory, not the provider's own facility.
| Provider Taxonomy Code | Specialty Name |
|---|---|
291U00000X | Clinical Medical Laboratory |
207Q00000X | Family Medicine Physician |
207R00000X | Internal Medicine Physician |
These taxonomies represent the types of providers or facilities typically involved in ordering or performing the CK total test.
Related Diagnoses
-
R74.8- Abnormal levels of other serum enzymes- Indicates abnormal enzyme levels detected in blood, relevant for CK testing to identify muscle or tissue injury.
-
I21.9- Acute myocardial infarction, unspecified- Used when evaluating for heart attack; CK levels can be elevated in myocardial infarction.
-
M62.82- Rhabdomyolysis- CK testing is essential for diagnosing rhabdomyolysis, a condition involving muscle breakdown.
-
I25.10- Atherosclerotic heart disease of native coronary artery without angina pectoris- CK may be measured in patients with coronary artery disease to assess for possible cardiac events.
-
R53.1- Weakness- Generalized weakness may prompt CK testing to rule out muscle injury or disease.
Related CPT Codes
82552- Creatine kinase isoenzymes
82552 is used to measure specific isoenzymes of creatine kinase, which can help differentiate between muscle, heart, or brain sources of elevated CK. This code is related to 82550 and may be used in conjunction when further differentiation of CK elevation is clinically necessary. 82550 measures total CK, while 82552 provides more detailed isoenzyme analysis.
National Reimbursement Benchmarks
National mean rates for CPT code 82550 show that BUCA (the average commercial benchmark) is $7.13, while Medicare rates are not available in the input. Among individual commercial payers, Cigna has the highest mean rate at $9.35, and UnitedHealth Group has the lowest at $5.91.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies across payers. UnitedHealth Group exhibits the tightest range ($3.00), indicating less variability in rates, while Cigna has the widest range ($5.00), reflecting greater variability. Blue Cross Blue Shield and BUCA both have moderate dispersion ($2.25 and $3.33, respectively).
The table and chart below present a detailed breakdown of national benchmarks for CPT code 82550 by payer, including mean rates and percentile values.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.